Altrova Health Income Statement

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Apr '23 Apr 30, 2023
Revenue	0.03	0.03	-	-	-
Cost of Revenue	0.05	0.05	-	-	-
Gross Profit	-0.02	-0.02	-	-	-
Selling, General & Admin	1.07	1	2.3	2.2	3.47
Operating Expenses	1.53	1.37	4.33	2.2	3.47
Operating Income	-1.55	-1.39	-4.33	-2.2	-3.47
Interest Expense	-	-	-	-	-0
Interest & Investment Income	0	-	0	0.01	-
Currency Exchange Gain (Loss)	0	-0	-0	0.01	-
Other Non Operating Income (Expenses)	-0.19	-0.22	-0.35	-7.28	-
EBT Excluding Unusual Items	-1.73	-1.61	-4.69	-9.46	-3.47
Merger & Restructuring Charges	-0.24	-0.24	-	-	-
Impairment of Goodwill	-2.49	-2.49	-	-	-
Gain (Loss) on Sale of Investments	-0.03	-0.03	-0.34	-	-
Gain (Loss) on Sale of Assets	-0.07	-0.07	-	-	-
Other Unusual Items	0.15	0.15	-	-	-
Pretax Income	-4.4	-4.28	-5.02	-9.46	-3.47
Net Income	-4.4	-4.28	-5.02	-9.46	-3.47
Net Income to Common	-4.4	-4.28	-5.02	-9.46	-3.47
Shares Outstanding (Basic)	164	139	75	31	-
Shares Outstanding (Diluted)	164	139	75	31	-
Shares Change (YoY)	108.26%	84.69%	141.97%	-	-
EPS (Basic)	-0.03	-0.03	-0.07	-0.30	-
EPS (Diluted)	-0.03	-0.03	-0.07	-0.30	-
Free Cash Flow	-0.89	-0.96	-3.06	-1.39	0.38
Free Cash Flow Per Share	-0.01	-0.01	-0.04	-0.04	-
Gross Margin	-60.55%	-60.55%	-	-	-
Operating Margin	-5251.75%	-4717.12%	-	-	-
Profit Margin	-14933.10%	-14522.72%	-	-	-
Free Cash Flow Margin	-3005.98%	-3255.27%	-	-	-
EBITDA	-1.53	-1.39	-4.33	-	-
D&A For EBITDA	0.02	0	0	-	-
EBIT	-1.55	-1.39	-4.33	-2.2	-3.47

Source: S&P Global Market Intelligence. Standard template. Financial Sources.